Brazil, University Of Texas Sign Agreement To Develop Zika Vaccine

Associated Press: Brazil, Texas state hospital reach deal on Zika vaccine
“Brazil has signed an agreement with a Texas research hospital to develop a vaccine against the Zika virus, the country’s health minister said Thursday, adding the goal is for the vaccine to be ready for clinical testing within 12 months…” (Goodman, 2/11).

BBC News: Zika virus: Brazil hopes to develop vaccine in ‘one year’
“…But two more years would be needed for any large-scale rollout, the health minister said…” (2/11).

Bloomberg Business: Brazil Partners With U.S. Scientists to Develop Zika Vaccine
“…The government will fund research by scientists in Brazil and at the University of Texas Medical Branch with $1.9 million over five years, the Health Ministry said in a statement…” (Edgerton/Santos, 2/11).

Wall Street Journal: Brazil, University of Texas to Work on Zika Vaccine
“…The governments of Brazil and the U.S. have already agreed to work together to develop a vaccine for Zika. Presidents Dilma Rousseff and Barack Obama spoke by telephone in late January and said they’ll broaden the cooperation on a vaccine for dengue fever to include Zika…” (Jelmayer/Lewis, 2/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.